AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.300
  • +0.025+9.09%
20min DelayMarket Closed Apr 24 16:00 AET
116.83MMarket Cap-1.50P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Paradigm Biopharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 0.000--
--2025/FY-- / 3.000M--
--2024/FY65.800K / 0.000--
--2023/FY46.760K / 5.000K--
--2022/FY79.220K / ----
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 0.000--
--2025/FY-- / 3.000M--
--2024/FY65.800K / 0.000--
--2023/FY46.760K / 5.000K--
--2022/FY79.220K / ----

Unlock Free Earnings Estimates

Paradigm Biopharmaceuticals Ltd Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More